Company will spotlight sustainable solutions to enhance patient safety, workforce well-being, and care delivery efficiency ...

Babson Diagnostics, a science-first healthcare technology company, today announced that BetterWay™ blood testing is a ...

In a notable performance, Becton Dickinson and Co. (NYSE:BDX) stock achieved a 52-week high, reaching a price level of ...

Atomi Financial Group Inc. lifted its position in Becton, Dickinson and Company (NYSE:BDX – Free Report) by 25.3% in the ...

Brighton Jones LLC raised its holdings in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) by 98.2% in the ...

The global prevalence of infectious diseases and the necessity for highly effective testing solutions to effectively manage <a target=_blank href= ...

Subcutaneous Drug Delivery Devices Market To Reach USD 56.95 Billion By 2032, Growing At A CAGR Of 7.07% - SNS Insider Subcutaneous Drug Delivery Devices market Growth Fueled by Chronic Diseases and ...

Allison Burk's teenage daughter struggled with uncontrolled emotions, a shrinking attention span and a growing tendency to procrastinate. A family doctor suggested ADHD testing, which led ...

The growing geriatric population will further boost the adoption of pain monitoring devices and will lead to an increase in ...

The effective date for a Genetic Testing in Oncology: Specific Test Local Coverage Determination (LCD) by Medicare in the US has been extended by two months to April 24, 2025. The change was ...

In 2023, the catheter market is projected to surge to a size of around USD 12,591.30 million. In the forecast period from ...